{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T03:10:34Z","timestamp":1773889834264,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,18]]},"DOI":"10.7759\/cureus.105464","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:37:22Z","timestamp":1773877042000},"source":"Crossref","is-referenced-by-count":0,"title":["De-escalation of Axillary Surgery in Early-Stage Breast Cancer: A Comprehensive Narrative Review"],"prefix":"10.7759","author":[{"given":"Sweta","family":"Munagapati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnav","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"35","author":"Loibl S","year":"2024","unstructured":"Loibl S, Andr\u00e9 F, Bachelot T, et al.. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024, 35:159-82. 10.1016\/j.annonc.2023.11.016","journal-title":"Ann Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21535","article-title":"Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection","volume":"102","author":"Ashikaga T","year":"2010","unstructured":"Ashikaga T, Krag DN, Land SR, et al.. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010, 102:111-8. 10.1002\/jso.21535","journal-title":"J Surg Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis","volume":"14","author":"DiSipio T","year":"2013","unstructured":"DiSipio T, Rye S, Newman B, et al.. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013, 14:500-15. 10.1016\/S1470-2045(13)70076-7","journal-title":"Lancet Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag DN","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, et al.. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010, 11:927-33. 10.1016\/S1470-2045(10)70207-2","journal-title":"Lancet Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial","volume":"98","author":"Mansel RE","year":"2006","unstructured":"Mansel RE, Fallowfield L, Kissin M, et al.. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst. 2006, 98:599-609. 10.1093\/jnci\/djj158","journal-title":"J Natl Cancer Inst"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","volume":"19","author":"Galimberti V","year":"2018","unstructured":"Galimberti V, Cole BF, Viale G, et al.. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol. 2018, 19:1385-93. 10.1016\/S1470-2045(18)30380-2","journal-title":"Lancet Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano AE","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, et al.. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017, 318:918-26. 10.1001\/jama.2017.11470","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2569-y","article-title":"Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000","volume":"20","author":"Sol\u00e1 M","year":"2013","unstructured":"Sol\u00e1 M, Alberro JA, Fraile M, et al.. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000. Ann Surg Oncol. 2013, 20:120-7. 10.1245\/s10434-012-2569-y","journal-title":"Ann Surg Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01565","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial","volume":"41","author":"Bartels SA","year":"2023","unstructured":"Bartels SA, Donker M, Poncet C, et al.. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial. J Clin Oncol. 2023, 41:2159-65. 10.1200\/JCO.22.01565","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker M","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, et al.. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014, 15:1303-10. 10.1016\/S1470-2045(14)70460-7","journal-title":"Lancet Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2016.12.011","article-title":"Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial","volume":"43","author":"S\u00e1volt \u00c1","year":"2017","unstructured":"S\u00e1volt \u00c1, P\u00e9ley G, Polg\u00e1r C, et al.. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial. Eur J Surg Oncol. 2017, 43:672-9. 10.1016\/j.ejso.2016.12.011","journal-title":"Eur J Surg Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2313487","article-title":"Omitting axillary dissection in breast cancer with sentinel-node metastases","volume":"390","author":"de Boniface J","year":"2024","unstructured":"de Boniface J, Filtenborg Tvedskov T, Ryd\u00e9n L, et al.. Omitting axillary dissection in breast cancer with sentinel-node metastases. N Engl J Med. 2024, 390:1163-75. 10.1056\/NEJMoa2313487","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.3759","article-title":"Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial","volume":"9","author":"Gentilini OD","year":"2023","unstructured":"Gentilini OD, Botteri E, Sangalli C, et al.. Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial. JAMA Oncol. 2023, 9:1557-64. 10.1001\/jamaoncol.2023.3759","journal-title":"JAMA Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2412063","article-title":"Axillary surgery in breast cancer - primary results of the INSEMA trial","volume":"392","author":"Reimer T","year":"2025","unstructured":"Reimer T, Stachs A, Veselinovic K, et al.. Axillary surgery in breast cancer - primary results of the INSEMA trial. N Engl J Med. 2025, 392:1051-64. 10.1056\/NEJMoa2412063","journal-title":"N Engl J Med"},{"key":"ref15","unstructured":"Axillary management for patients with in-situ and invasive breast cancer. a concise overview. (2022). Accessed: February 12, 2026: https:\/\/www.breastsurgeons.org\/docs\/statements\/asbrs-management-of-the-axilla.pdf."},{"key":"ref16","unstructured":"Five things physicians and patients should question. choosing wisely. (2019). Accessed: February 12, 2026: https:\/\/www.surgonc.org\/wp-content\/uploads\/2020\/11\/SSO-5things-List_2020-Updates-11-2020.pdf."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-00099","article-title":"Sentinel lymph node biopsy in early-stage breast cancer: ASCO guideline update","volume":"43","author":"Park KU","year":"2025","unstructured":"Park KU, Somerfield MR, Anne N, et al.. Sentinel lymph node biopsy in early-stage breast cancer: ASCO guideline update. J Clin Oncol. 2025, 43:1720-41. 10.1200\/JCO-25-00099","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1200\/OP-25-00447","article-title":"Sentinel lymph node biopsy in early-stage breast cancer: ASCO guideline clinical insights","author":"Park KU","year":"2025","unstructured":"Park KU, Vega RB, Shams S, Hawley J, Somerfield MR, Thompson AM, Torres MA. Sentinel lymph node biopsy in early-stage breast cancer: ASCO guideline clinical insights. JCO Oncol Pract. 2025, OP2500447. 10.1200\/OP-25-00447","journal-title":"JCO Oncol Pract"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau JF","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M, et al.. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015, 33:258-64. 10.1200\/JCO.2014.55.7827","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey JC","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, et al.. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013, 310:1455-61. 10.1001\/jama.2013.278932","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle AS","year":"2016","unstructured":"Caudle AS, Yang WT, Krishnamurthy S, et al.. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016, 34:1072-8. 10.1200\/JCO.2015.64.0094","journal-title":"J Clin Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn T","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, et al.. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013, 14:609-18. 10.1016\/S1470-2045(13)70166-9","journal-title":"Lancet Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1415369","article-title":"Internal mammary and medial supraclavicular irradiation in breast cancer","volume":"373","author":"Poortmans PM","year":"2015","unstructured":"Poortmans PM, Collette S, Kirkove C, et al.. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015, 373:317-27. 10.1056\/NEJMoa1415369","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30472-1","article-title":"Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial","volume":"21","author":"Poortmans PM","year":"2020","unstructured":"Poortmans PM, Weltens C, Fortpied C, et al.. Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial. Lancet Oncol. 2020, 21:1602-10. 10.1016\/S1470-2045(20)30472-1","journal-title":"Lancet Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan TJ","year":"2015","unstructured":"Whelan TJ, Olivotto IA, Parulekar WR, et al.. Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015, 373:307-16. 10.1056\/NEJMoa1415340","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.1984","article-title":"Radiotherapy use and incidence of locoregional recurrence in patients with favorable-risk, node-positive breast cancer enrolled in the SWOG S1007 trial","volume":"9","author":"Jagsi R","year":"2023","unstructured":"Jagsi R, Barlow WE, Woodward WA, et al.. Radiotherapy use and incidence of locoregional recurrence in patients with favorable-risk, node-positive breast cancer enrolled in the SWOG S1007 trial. JAMA Oncol. 2023, 9:1083-9. 10.1001\/jamaoncol.2023.1984","journal-title":"JAMA Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2023.01.002","article-title":"Omission of axillary sentinel lymph node biopsy in early invasive breast cancer","volume":"67","author":"Reimer T","year":"2023","unstructured":"Reimer T. Omission of axillary sentinel lymph node biopsy in early invasive breast cancer. Breast. 2023, 67:124-8. 10.1016\/j.breast.2023.01.002","journal-title":"Breast"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3443-x","article-title":"Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)","volume":"17","author":"van Roozendaal LM","year":"2017","unstructured":"van Roozendaal LM, Vane ML, van Dalen T, et al.. Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08). BMC Cancer. 2017, 17:459. 10.1186\/s12885-017-3443-x","journal-title":"BMC Cancer"},{"key":"ref29","unstructured":"Comparison of axillary lymph node dissection with axillary radiation for patients with node-positive breast cancer treated with chemotherapy. (2025). Accessed. February 12, 2026: https:\/\/clinicaltrials.gov\/study\/NCT01901094."},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10041","article-title":"Systematic review of axillary reverse mapping in breast cancer","volume":"103","author":"Ahmed M","year":"2016","unstructured":"Ahmed M, Rubio IT, Kovacs T, Klimberg VS, Douek M. Systematic review of axillary reverse mapping in breast cancer. Br J Surg. 2016, 103:170-8. 10.1002\/bjs.10041","journal-title":"Br J Surg"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s40137-024-00433-9","article-title":"Immediate lymphatic reconstruction: an overview and current evidence","volume":"13","author":"Kadle R","year":"2025","unstructured":"Kadle R, Skoracki R. Immediate lymphatic reconstruction: an overview and current evidence. Curr Surg Rep. 2025, 13:5. 10.1007\/s40137-024-00433-9","journal-title":"Curr Surg Rep"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.109377","article-title":"The efficacy of immediate lymphatic reconstruction after axillary lymph node dissection - a meta-analysis","volume":"51","author":"Wong AW","year":"2025","unstructured":"Wong AW, Sim NH, Zhan SJ, Huang JJ. The efficacy of immediate lymphatic reconstruction after axillary lymph node dissection - a meta-analysis. Eur J Surg Oncol. 2025, 51:109377. 10.1016\/j.ejso.2024.109377","journal-title":"Eur J Surg Oncol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-054365","article-title":"POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes","volume":"11","author":"Goyal A","year":"2021","unstructured":"Goyal A, Mann GB, Fallowfield L, et al.. POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes. BMJ Open. 2021, 11:e054365. 10.1136\/bmjopen-2021-054365","journal-title":"BMJ Open"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS611","article-title":"Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast (OPBC-03\/SAKK 23\/16\/IBCSG 57-18\/ABCSG-53\/GBG-101-TAXIS)","volume":"42","author":"Weber WP","year":"2024","unstructured":"Weber WP, Matrai Z, Hayoz S, et al.. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast (OPBC-03\/SAKK 23\/16\/IBCSG 57-18\/ABCSG-53\/GBG-101-TAXIS). J Clin Oncol. 2024, 42:TPS611. 10.1200\/JCO.2024.42.16_suppl.TPS611","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/468831-de-escalation-of-axillary-surgery-in-early-stage-breast-cancer-a-comprehensive-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:37:25Z","timestamp":1773877045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/468831-de-escalation-of-axillary-surgery-in-early-stage-breast-cancer-a-comprehensive-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.105464","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,18]]}}}